MCID: GLL017
MIFTS: 43

Gallbladder Adenocarcinoma malady

Summaries for Gallbladder Adenocarcinoma

Sources:
33MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
MalaCards: Gallbladder Adenocarcinoma, also known as adenocarcinoma of the gallbladder, is related to adenocarcinoma and large cell carcinoma. An important gene associated with Gallbladder Adenocarcinoma is MUC2 (mucin 2, oligomeric mucus/gel-forming), and among its related pathways are IL-3 Signaling Pathway and TGF-Beta Pathway. The compounds butyrate and o-tyrosine have been mentioned in the context of this disorder. Related mouse phenotypes are embryogenesis and integument.

Aliases & Classifications for Gallbladder Adenocarcinoma

Sources:
8Disease Ontology, 61UMLS, 40NCIt
See all sources

Aliases & Descriptions:

gallbladder adenocarcinoma 8 61
adenocarcinoma of the gallbladder 8


External Ids:

Disease Ontology8 DOID:3500
NCIt40 C9166

Related Diseases for Gallbladder Adenocarcinoma

Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Gallbladder Adenocarcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 130)
idRelated DiseaseScoreTop Affiliating Genes
1adenocarcinoma31.4JAK2, CHGA, MYC, TYMP, MUC2, MUC1
2large cell carcinoma30.4CHGA, KRAS, ERBB2
3gastrointestinal stromal tumor30.0IFI27
4signet ring cell adenocarcinoma30.0CHGA, MUC2
5adenosquamous carcinoma30.0NME1, MUC1, MUC2, TYMP, CHGA
6ulcerative colitis30.0MUC2, SRC, LAMC2, SELE
7adenoma30.0MUC2, MYC, CHGA, IFI27, BRAF, MUC1
8neuroendocrine carcinoma10.4
9acanthosis nigricans10.3
10mucinous adenocarcinoma10.3
11xanthogranulomatous cholecystitis10.2
12acute interstitial pneumonia10.2
13gallbladder small cell carcinoma10.2
14gallbladder pleomorphic giant cell adenocarcinoma10.2
15small cell carcinoma10.2
16choledochal cyst10.2
17bile duct mucinous adenocarcinoma10.2
18bile duct adenocarcinoma10.2
19somatostatin analog10.2
20congenital pancreatic cyst10.2
21acalculous cholecystitis10.0
22gallbladder signet ring cell adenocarcinoma10.0
23adenosquamous gallbladder carcinoma10.0
24krukenberg carcinoma10.0
25sclerosing cholangitis10.0
26ampulla of vater carcinoma10.0MUC2
27pancreatitis10.0KRAS
28endometriosis10.0TYMP
29leiomyoma10.0TYMP
30ductal carcinoma in situ10.0ERBB2
31neurofibromatosis10.0KRAS
32gastritis10.0CHGA
33pneumonia10.0MUC1
34rhabdoid tumor10.0MUC1
35angiosarcoma10.0MUC1
36laryngeal squamous cell carcinoma10.0NME1, IFI27
37oral cancer10.0CD82, IFI27
38biliary papillomatosis10.0MUC2
39hepatitis10.0TYMP, KRAS
40myelofibrosis10.0JAK2
41juvenile myelomonocytic leukemia10.0KRAS
42leiomyosarcoma10.0MUC1
43gallbladder cancer10.0KRAS, MUC2
44cervical squamous cell carcinoma10.0KRAS, TYMP
45pituitary tumors10.0CHGA, IFI27
46papilloma10.0IFI27, SRC
47cervical intraepithelial neoplasia10.0IFI27, NME1
48neuroblastoma10.0NME1, MYC
49cystadenoma10.0BRAF, KRAS
50cervical adenocarcinoma10.0IFI27, NME1, LAMC2

Graphical network of the top 20 diseases related to Gallbladder Adenocarcinoma:



Diseases related to gallbladder adenocarcinoma

Clinical Features for Gallbladder Adenocarcinoma

Drugs & Therapeutics for Gallbladder Adenocarcinoma

Sources:
5CenterWatch, 42NIH Clinical Center, 6ClinicalTrials
See all sources

Approved drugs:

Search CenterWatch for Gallbladder Adenocarcinoma

Drug clinical trials:

Search ClinicalTrials for Gallbladder Adenocarcinoma

Search NIH Clinical Center for Gallbladder Adenocarcinoma

Search CenterWatch for Gallbladder Adenocarcinoma

Genetic Tests for Gallbladder Adenocarcinoma

Anatomical Context for Gallbladder Adenocarcinoma

Animal Models for Gallbladder Adenocarcinoma or affiliated genes

Sources:
37MGI, 28inGenious Targeting Laboratory
See all sources

Publications for Gallbladder Adenocarcinoma

Sources:
51PubMed
See all sources

Articles related to Gallbladder Adenocarcinoma:

(show top 50)    (show all 106)
idTitleAuthorsYear
1
Expression of Cell Cycle-Related Proteins, p16, p53 and p63 as Important Prognostic Markers in Gallbladder Adenocarcinoma. (24178677)
2013
2
Cutaneous metastasis of gallbladder adenocarcinoma in a patient with chronic lymphocytic leukemia: a case report and review of the literature. (23467457)
2013
3
ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. (23065574)
2013
4
Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: A propensity score-matched Surveillance, Epidemiology, and End Results analysis. (23876364)
2013
5
Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance. (23475628)
2013
6
CFL1 and Arp3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinomas of gallbladder. (23320827)
2013
7
A case of huge papillary adenocarcinoma of the gallbladder with marked necrosis]. (23303235)
2013
8
Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma. (23268317)
2013
9
Gallbladder adenocarcinoma: evaluation of the prognostic factors in 100 resectable cases in Brazil. (22569972)
2012
10
Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma. (22497866)
2012
11
Does impaired gallbladder function contribute to the development of Barrett's esophagus and esophageal adenocarcinoma? (21484485)
2011
12
Frequency of genetic alterations observed in cell cycle regulatory proteins and microsatellite instability in gallbladder adenocarcinoma: a translational perspective. (21545232)
2011
13
Giant gallbladder: adenocarcinoma complicated with empyema. (21217498)
2011
14
Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. (21719208)
2011
15
Ala499Val (C>T) and Lys939Gln (A>C) polymorphisms of the XPC gene: their correlation with the risk of primary gallbladder adenocarcinoma--a case-control study in China. (21113018)
2011
16
Curative resection of combined neuroendocrine carcinoma and adenocarcinoma of the gallbladder. (22322853)
2011
17
Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder. (20040392)
2010
18
Invasive micropapillary variant of the gallbladder adenocarcinoma and its aggressive potential for lymph node metastasis. (20460736)
2010
19
Gallbladder adenocarcinoma with human chorionic gonadotropin: a case report and review of literature. (20594358)
2010
20
Combined large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. (19945229)
2010
21
Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma. (19331129)
2009
22
Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines. (19209029)
2009
23
Spontaneous necrosis of solid gallbladder adenocarcinoma accompanied with pancreaticobiliary maljunction. (18855999)
2008
24
Gallbladder adenocarcinoma arising in Rokitansky-Aschoff sinus. (19067858)
2008
25
The impact of tumor extent (T stage) and lymph node involvement (N stage) on survival after surgical resection for gallbladder adenocarcinoma. (19088928)
2008
26
Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells. (16229013)
2006
27
A case of lepidic pulmonary metastasis from adenocarcinoma of the gallbladder mimicking acute interstitial pneumonia. (16223618)
2005
28
A comparative clinical study of gallbladder tubular adenocarcinoma according to the grade of differentiation. (15549451)
2004
29
Protease-activating-receptor-2 is frequently expressed in papillary adenocarcinoma of the gallbladder. (15492786)
2004
30
Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression. (11843061)
2002
31
Mucinous adenocarcinoma originating in localized type adenomyomatosis of the gallbladder. (11780399)
2001
32
Resection of triple synchronous tumors--gastric adenocarcinoma, gallbladder adenocarcinoma and stromal tumor of the stomach. (11853221)
2001
33
Fine needle aspiration cytology in xanthogranulomatous cholecystitis, gallbladder adenocarcinoma and coexistent lesions. (10934941)
2000
34
Hepatoid adenocarcinoma of the gallbladder. (10982619)
2000
35
Gallbladder Adenocarcinoma with Florid Neuroendocrine Cell Nests and Extensive Paneth Cell Metaplasia. (12114761)
2000
36
v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells. (10048975)
1999
37
Subacute pulmonary hypertension due to pulmonary tumor microembolism as a clinical manifestation of occult gallbladder adenocarcinoma. (9070964)
1997
38
Gallbladder adenocarcinoma and acalculous chronic lymphoplasmacytic cholecystitis associated with ulcerative colitis [corrected]. (8685213)
1996
39
Differentiation towards gastric foveolar, mucopeptic and intestinal goblet cells in gallbladder adenocarcinomas. (8951489)
1996
40
Gallbladder adenocarcinoma with gallstone and calcified ova of clonorchis sinensis--a case report. (8205506)
1994
41
Adenocarcinoma of the gallbladder associated with congenital choledochal cyst and anomalous pancreaticobiliary ductal junction. Case report. (1683581)
1991
42
Xanthogranulomatous cholecystitis associated with gallbladder adenocarcinoma. A clinicopathological study of 5 cases. (1746061)
1991
43
Morphometric analysis of gallbladder adenocarcinoma: discrimination between carcinoma and dysplasia. (2512741)
1989
44
A human gallbladder adenocarcinoma cell line. (2680052)
1989
45
Dysplasia of the gallbladder. Its histogenesis and correlation to gallbladder adenocarcinoma. (2602218)
1989
46
Gallbladder adenocarcinoma: the prognostic significance of histologic grade. (3807370)
1987
47
Gallbladder adenocarcinoma: prognostic significance of tumor acid mucopolysaccharide content. (2946897)
1986
48
Acanthosis nigricans associated with adenocarcinoma of the gallbladder. (4050764)
1985
49
Triplication of the gallbladder with cholecystitis, cholelithiasis, and papillary adenocarcinoma. (5089579)
1971
50
Primary papillary adenocarcinoma of the fundus of the gallbladder. (18110755)
1949

Genetic Variations for Gallbladder Adenocarcinoma

Expression for genes affiliated with Gallbladder Adenocarcinoma

Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Gallbladder Adenocarcinoma

Search GEO for disease gene expression data for Gallbladder Adenocarcinoma.

Pathways for genes affiliated with Gallbladder Adenocarcinoma

Sources:
38NCBI BioSystems Database, 52QIAGEN, 12EMD Millipore, 54Reactome, 30KEGG, 4Cell Signaling Technology, 56SinoBiological, 50PharmGKB, 53R&D Systems
See all sources

Pathways related to Gallbladder Adenocarcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 66)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
110.2SRC, TYK2
2
Hide members
10.2ERBB2, EPHA7
3
Hide members
10.1SRC, PTK2B
410.1SRC, ERBB2, LAMC2
510.0TYK2, JAK2, SRC
610.0JAK2, TYK2, SRC
710.0SRC, TYK2, JAK2
810.0TYK2, MYC, JAK2
910.0JAK2, TYK2, MYC
10
Hide members
10.0KRAS, SRC, BRAF
1110.0BRAF, MYC, KRAS
12
Development EPO-induced Jak-STAT pathway
Hide members
10.0MYC, JAK2, SRC
1310.0JAK2, TYK2, PTK2B
1410.0JAK2, PTK2B, KRAS
1510.0SRC, PTK2B, ERBB2
169.9SRC, PTK2B, JAK2
17
Hide members
9.9JAK2, SRC, KRAS, ERBB2
189.9MUC1, JAK2, SRC, ERBB2
19
Hide members
9.9PTK2B, KRAS, TYK2, JAK2
20
Hide members
9.9ERBB2, KRAS, BRAF, MYC
219.8PTK2B, JAK2, TYK2, ERBB2
22
Hide members
9.8ERBB2, KRAS, SRC, PTK2B
239.8SRC, BRAF, JAK2, MYC
24
Hide members
9.8PTK2B, SRC, KRAS, MYC
25
Immune response IFN gamma signaling pathway
Hide members
9.8JAK2, PTK2B, SRC, MYC
269.7ERBB2, LAMC2, KRAS, MYC, BRAF
27
Hide members
9.7BRAF, KRAS, TYMP, MYC, SRC
28
Hide members
9.7SELE, KRAS, SRC, BRAF, JAK2
29
Development Prolactin receptor signaling
Hide members
9.7ERBB2, JAK2, MYC, KRAS, SRC
30
Hide members
9.7BRAF, MYC, KRAS, SRC, ERBB2
319.7KRAS, SRC, BRAF, ERBB2, MYC
32
Hide members
9.7KRAS, MYC, BRAF, ERBB2, SRC
33
Development PDGF signaling via STATs and NF-kB
Hide members
9.7SRC, TYK2, JAK2, MYC, PTK2B
34
Hide members
9.7BRAF, MYC, JAK2, SRC, ERBB2
35
Hide members
9.7PTK2B, ERBB2, SRC, LAMC2, BRAF
36
Hide members
9.7KRAS, PTK2B, JAK2, IFI27, TYK2
379.6PTK2B, MYC, KRAS, SRC, JAK2
38
Hide members
9.6JAK2, KRAS, SRC, PTK2B, BRAF
39
Hide members
9.6SRC, PTK2B, BRAF, JAK2, KRAS
40
Hide members
9.6BRAF, ERBB2, PTK2B, SRC, JAK2
41
Hide members
9.6EPHA7, SRC, JAK2, MYC, TYK2, ERBB2
429.6MYC, ERBB2, SRC, KRAS, NME1, CD82
43
G-protein signaling Ras family GTPases in kinase cascades (scheme)
Hide members
9.5SRC, TYK2, PTK2B, JAK2, BRAF, KRAS
44
Hide members
9.5JAK2, ERBB2, MYC, MUC1, SRC, BRAF
45
Translation Insulin regulation of translation
Hide members
9.5PTK2B, BRAF, JAK2, KRAS, SRC, ERBB2
46
Hide members
9.5MYC, SRC, LAMC2, BRAF, PTK2B, JAK2
47
Hide members
9.5MYC, KRAS, SRC, PTK2B, ERBB2, BRAF
48
Hide members
9.4BRAF, JAK2, MYC, TYK2, MUC1, KRAS
49
Hide members
9.3SRC, PTK2B, EPHA7, MYC, JAK2, BRAF
50
Hide members
9.1EPHA7, ERBB2, SRC, LAMC2, JAK2, BRAF

Compounds for genes affiliated with Gallbladder Adenocarcinoma

Sources:
45Novoseek, 50PharmGKB, 60Tocris Bioscience, 11DrugBank, 29IUPHAR, 24HMDB, 2BitterDB
See all sources

Compounds related to Gallbladder Adenocarcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 124)
idCompoundScoreTop Affiliating Genes
1butyrate4510.5JAK2
2o-tyrosine4510.3TYK2, ERBB2, JAK2
3crcs4510.1MUC2, MUC1, NME1, KRAS, TYMP, BRAF
4etoposide45 50 60 1113.1ERBB2, CHGA, SELE, PTK2B
5cycloheximide4510.1TYMP
6gemcitabine45 50 1112.0MYC, TYMP, MUC1, SRC, ERBB2
7matrigel4510.0SRC, NME1, SELE, MUC1, JAK2, BRAF
8erlotinib45 50 1112.0ERBB2, SRC, TYMP, KRAS
9vanadate4510.0SOAT1, PTK2B, SRC, TYK2, JAK2
10sodium orthovanadate45 6011.0TYK2, JAK2, PTK2B, SRC
11dexamethasone45 50 29 1112.9PTK2B, NME1, MUC2, MYC, SOAT1, IFI27
12folate459.9SELE, ERBB2, PTK2B, MUC1, TYMP, MYC
13p002459.9CHGA, ERBB2, KRAS, NME1, TYMP, IFI27
14dmso459.8CHGA, MYC, SELE, MUC2, MUC1, PTK2B
15herbimycin a45 6010.8SRC, JAK2, MYC, SELE, PTK2B, ERBB2
16aspirin45 50 29 2412.8PTK2B, TYMP, ERBB2, SELE, JAK2, SRC
1712-o-tetradecanoylphorbol 13-acetate459.8BRAF, JAK2, CHGA, TYMP, MUC2, MUC1
18serine459.7ERBB2, JAK2, MUC2, NME1, KRAS, SRC
19adp45 29 2411.7PTK2B, NME1, EPHA7, TYK2, JAK2
20guanine45 11 2411.7IFI27, SELE, ERBB2, PTK2B, SRC, TYMP
21phosphotyrosine459.7PTK2B, SOAT1, ERBB2, TYK2, SRC, JAK2
22sb 20358045 6010.7SELE, BRAF, PTK2B, JAK2, SRC, MUC2
23tamoxifen45 50 29 1112.7SELE, ERBB2, TYMP, MUC1, MYC, CHGA
24paclitaxel45 50 1111.6BRAF, IFI27, SRC, TYMP, ERBB2, CHGA
255fluorouracil459.6MUC2, SRC, KRAS, PTK2B, ERBB2, SELE
26agar459.6BRAF, MUC1, JAK2, MYC, NME1, SRC
27genistein45 29 60 2 11 2414.6PTK2B, SRC, JAK2, IFI27, SELE, MYC
28actinomycin d459.6MUC2, SOAT1, JAK2, PTK2B, MUC1, TYMP
29thymidine45 2410.6NME1, TYMP, MUC1, IFI27, MYC, PTK2B
30phosphoinositide459.6BRAF, IFI27, SOAT1, JAK2, KRAS, SRC
31imatinib45 50 1111.6ERBB2, PTK2B, SRC, KRAS, MYC, JAK2
32n acetylcysteine459.5SRC, ERBB2, PTK2B, MYC, JAK2, SOAT1
33progesterone45 60 29 11 2413.5NME1, BRAF, TYMP, IFI27, MUC2, CHGA
34pd 98,059459.5BRAF, SOAT1, MYC, MUC2, SRC, JAK2
35wortmannin459.5TYMP, ERBB2, PTK2B, BRAF, SOAT1, JAK2
36testosterone45 60 11 2412.5IFI27, SOAT1, CHGA, SRC, PTK2B, SELE
37oligonucleotide459.4IFI27, BRAF, JAK2, CHGA, SOAT1, MYC
38cysteine459.4MUC2, NME1, SRC, TYMP, JAK2, PTK2B
39rapamycin459.4ERBB2, BRAF, IFI27, SOAT1, JAK2, MYC
40paraffin459.3MYC, TYMP, KRAS, ERBB2, MUC2, MUC1
41Adenosine triphosphate11 2410.3JAK2, TYK2, EPHA7, NME1, SRC, PTK2B
42alanine459.3PTK2B, SOAT1, JAK2, MYC, TYK2, NME1
43threonine459.2SOAT1, JAK2, MYC, TYK2, MUC2, MUC1
44phosphatidylinositol459.2BRAF, SOAT1, JAK2, MYC, TYK2, KRAS
45cyclic amp45 2410.1BRAF, IFI27, SOAT1, CHGA, MUC1, MCAM
46ly294002459.1MYC, BRAF, IFI27, JAK2, TYMP, TYK2
47cisplatin45 50 60 1112.1SRC, TYMP, MYC, CHGA, JAK2, IFI27
48retinoic acid45 2410.1NME1, PTK2B, MYC, KRAS, MUC1, CHGA
49vegf458.7BRAF, IFI27, SOAT1, JAK2, SELE, PTK2B
50tyrosine458.3MYC, MCAM, ERBB2, BRAF, IFI27, SOAT1

GO Terms for genes affiliated with Gallbladder Adenocarcinoma

Sources:
16Gene Ontology
See all sources

Cellular components related to Gallbladder Adenocarcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1caveolaGO:00590110.0SELE, SRC, JAK2
2membrane raftGO:0451219.5SELE, PTK2B, KRAS, JAK2

Biological processes related to Gallbladder Adenocarcinoma according to GeneCards/GeneDecks:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1enzyme linked receptor protein signaling pathwayGO:00716710.3ERBB2, JAK2
2activation of MAPKK activityGO:00018610.3KRAS, JAK2, BRAF
3positive regulation of epithelial cell proliferationGO:05067910.3MYC, NME1, ERBB2
4signal complex assemblyGO:00717210.3PTK2B, SRC
5peptidyl-tyrosine phosphorylationGO:01810810.2JAK2, SRC, PTK2B
6regulation of ERK1 and ERK2 cascadeGO:07037210.2ERBB2, EPHA7
7MAPK cascadeGO:00016510.2PTK2B, KRAS, MYC
8fibroblast growth factor receptor signaling pathwayGO:00854310.1BRAF, KRAS, SRC, ERBB2
9positive regulation of nitric-oxide synthase activityGO:05100010.1PTK2B, KRAS
10protein autophosphorylationGO:04677710.1JAK2, SRC, PTK2B, ERBB2
11epidermal growth factor receptor signaling pathwayGO:00717310.1ERBB2, PTK2B, SRC, KRAS
12cytokine-mediated signaling pathwayGO:01922110.1IFI27, JAK2, TYK2, KRAS
13protein phosphorylationGO:00646810.0ERBB2, PTK2B, TYK2, JAK2, BRAF
14intracellular protein kinase cascadeGO:0072439.9JAK2, TYK2, SRC
15neurotrophin TRK receptor signaling pathwayGO:0480119.9BRAF, KRAS, SRC, ERBB2
16positive regulation of ERK1 and ERK2 cascadeGO:0703749.6PTK2B, SRC, BRAF

Molecular functions related to Gallbladder Adenocarcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1growth hormone receptor bindingGO:00513110.2TYK2, JAK2
2non-membrane spanning protein tyrosine kinase activityGO:0047159.8JAK2, TYK2, SRC, PTK2B
3protein tyrosine kinase activityGO:0047139.6ERBB2, PTK2B, SRC, EPHA7, TYK2, JAK2
4ATP bindingGO:0055249.0BRAF, JAK2, TYK2, EPHA7, NME1, SRC
5protein bindingGO:0055158.1BRAF, SOAT1, JAK2, MYC, TYK2, MUC2

Products for genes affiliated with Gallbladder Adenocarcinoma

  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Gallbladder Adenocarcinoma

3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
51PubMed
52QIAGEN
58SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet